Since a majority of head and neck squamous cell carcinoma tumours express or overexpress epidermal growth factor receptor, the epidermal growth factor receptor inhibitors including cetuximab has been tried in these patients. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.